Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 14, 2021 09:00 ET | Source: Headlands Research

Headlands Research CEO Mark Blumling to Speak at Milken Institute Global Conference

SAN FRANCISCO, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that Founder and CEO...
June 16, 2021 09:00 ET | Source: Headlands Research

Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease

SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, is pleased to have supported Biogen...
February 17, 2021 09:00 ET | Source: Headlands Research

Headlands Research Accelerates Growth and Diversity Commitment with the Acquisition of Multi-Site Southern California Based Artemis Institute for Clinical Research

SAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Headlands Research (www.headlandsresearch.com), a global next-generation clinical research site organization, today announced that it has acquired...
September 01, 2020 09:00 ET | Source: Headlands Research

First Patient Dosed in AstraZeneca’s Phase III COVID-19 Vaccine Trial at Headlands’ JEM Research Institute Site in Florida

SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Headlands Research is pleased to announce that on Friday, Aug. 28, its JEM Research Institute clinical trial site in Lake Worth, Florida,...
August 11, 2020 09:00 ET | Source: Headlands Research

Multiple Headlands Research Sites Selected for AstraZeneca’s Phase III COVID-19 Vaccine Trial

SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in AstraZeneca’s upcoming Phase III COVID-19 vaccine...
July 16, 2020 13:28 ET | Source: Headlands Research

Headlands Research Sites Chosen for Crucial COVID-19 Vaccine Trials

SAN FRANCISCO, July 16, 2020 (GLOBE NEWSWIRE) -- Headlands Research announced today that its research centers have been selected to participate in numerous upcoming COVID-19 vaccine clinical trials....
July 07, 2020 09:00 ET | Source: Headlands Research

Headlands Research Acquires CNS Global Site Leaders JEM Research Institute and Toronto Memory Program

SAN FRANCISCO, July 07, 2020 (GLOBE NEWSWIRE) -- Headlands Research, a global next-generation clinical research site organization, today announced its acquisition of two large central nervous system...